Please login to the form below

Not currently logged in
Email:
Password:

Communiqué Awards 2020 – online judging

Sandemann and Dunn

This year’s judging will now take place by video conference

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

Bluebird BioFirst patient is likely to be treated later in the year due to pandemic

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

Fallout from pandemic continues to affect business in myriad ways

Novartis forms coronavirus alliance with life sciences companies

Novartis buildingPartnership will accelerate research with aid of Gates Foundation

Gilead halts individual requests for COVID-19 hopeful remdesivir

GileadWill now focus on expanded access programmes and backlog

WHO partners with WhatsApp to provide accurate COVID-19 information

WHOSocial media platform will provide users with facts around virus

Bayer signs €250m pact with India’s Curadev for STING drugs

Bayer symbolResearch will focus on auto-immune and inflammatory diseases

Biogen joins COVID-19 efforts with $10m support fund

BiogenFunds will be used to address 'immediate critical needs'

Lilly joins new Medicare scheme to reduce insulin prices

Eli Lilly new HQNew model will cover seniors enrolled in Medicare Part D

Q&A: Elizabeth Egan

Elizabeth Egan is President of Havas Lynx Group

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Why we need to improve diverse representation in clinical trials
Diversity in clinical trials: The powerful need to improve it! “One size fits all” is rapidly becoming an outdated concept in modern-day life, and medical research is no exception. Without...

Infographics